Both agents were titrated up from starting doses of pioglitazone (30 mg daily) and metformin (500 mg twice daily) for 2 weeks; no adverse effects were reported.FIGURE 1Study flow diagram.For both studies, exclusion criteria included known CVD, liver or kidney disease, and other chronic diseases.